Pharmaceutical Rebates for Excessive Pricing Above Inflation Act or the Pharmaceutical REPAI Act
This bill requires drug manufacturers, subject to civil penalties, to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under the Medicare prescription drug benefit that cost $100 or more and for which the average manufacturer price increases faster than inflation.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2019-10-09 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2019-10-08 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2019-10-08 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2019-10-08 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2019-10-08 | IntroReferral | Introduced in House | Library of Congress |